JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bacher, A.
Right arrow Articles by Aloy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bacher, A.
Right arrow Articles by Aloy, A.
Anesth Analg 2000;91:1506-1512
© 2000 International Anesthesia Research Society


GENERAL ARTICLES

Respiratory Efficacy of Subglottic Low-Frequency, Subglottic Combined-Frequency, and Supraglottic Combined-Frequency Jet Ventilation During Microlaryngeal Surgery

Andreas Bacher, MD, Thomas Lang, MD, Johannes Weber, MD, and Alexander Aloy, MD

Department of Anesthesiology and General Intensive Care, University of Vienna, Austria

Address correspondence and reprint requests to Andreas Bacher, MD, Department of Anesthesiology and General Intensive Care, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Address e-mail to andreas.bacher{at}univie.ac.at


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
We tested the respiratory efficacy of different jet ventilation techniques (subglottic low-frequency versus subglottic combined-frequency and subglottic combined-frequency versus supraglottic combined frequency) in patients undergoing microlaryngeal surgery. The PaCO2 and the quotient of arterial oxygen tension (PaO2) over FIO2 were measured. After anesthetic induction (propofol, remifentanil, vecuronium), an endotracheal Mon-Jet catheter (Xomed, Jacksonville, FL) for subglottic jet ventilation and a laryngoscope for supraglottic jet ventilation (Carl Reiner G.m.b.H., Vienna, Austria) were inserted. In Group 1 (n = 18), subglottic low-frequency (15 breaths/min), combined-frequency (600 and 15 breaths/min), and low-frequency jet ventilation was subsequently performed (15 min each). In Group 2 (n = 19), the sequence was supraglottic, subglottic, and supraglottic combined-frequency jet ventilation. The driving pressures were initially adjusted to achieve normocapnia and were not changed during the entire study period. The FIO2 was measured endotracheally. The Wilcoxon’s signed rank test was applied. In Group 1, PaCO2 and PaO2/FIO2 improved significantly after switching from subglottic low-frequency to subglottic combined-frequency jet ventilation (PaCO2, from 46.6 ± 8.3 to 42.1 ± 8.1 mm Hg; PaO2/FIO2, from 311 ± 144 to 361 ± 141 mm Hg; P <0.05). In Group 2, PaCO2 increased and PaO2/FIO2 decreased significantly after switching from supraglottic to subglottic combined-frequency jet ventilation (PaCO2, from 39.4 ± 7.1 to 45.9 ± 7.5 mm Hg; PaO2/FIO2, from 415 ± 114 to 351 ± 129 mmHg; P <0.05). We conclude that subglottic combined-frequency jet ventilation is less effective than supraglottic combined-frequency ventilation, but more effective than subglottic low-frequency jet ventilation.

Implications: The combination of high and low respiratory frequencies (600 and 15 breaths/min) improves pulmonary gas exchange during subglottic jet ventilation via an endotracheal catheter. However, subglottic combined-frequency jet ventilation is less effective than supraglottic combined-frequency jet ventilation via a jet ventilation laryngoscope.


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Jet ventilation is a very useful technique for microlaryngeal surgery. It provides adequate pulmonary gas exchange as well as free surgical access and overview of the operating field (14). Jet ventilation may be performed in many different ways, such as high-, low-, or combined-frequency ventilation, and subglottic or supraglottic ventilation, with specially designed catheters or laryngoscopes. An optimal combination of ventilatory modes and access routes to improve the efficacy and safety of jet ventilation techniques has not been determined.

In a previous study, we compared the respiratory efficacy of supraglottic combined-frequency jet ventilation via a jet ventilation laryngoscope (Carl Reiner G.m.b.H., Vienna, Austria) and subglottic monofrequent jet ventilation via an endotracheal catheter (Mon-Jet; Xomed, Jacksonville, FL) (5). We found that supraglottic combined-frequency jet ventilation provides significantly better oxygenation and lower PaCO2 values at a given FIO2 and driving pressure, respectively (5). The question arising from these results was whether the observed superiority of supraglottic combined-frequency jet ventilation to subglottic monofrequent jet ventilation was a result of the simultaneous administration of combined respiratory frequencies (600 and 15 breaths/min), a result of the access route, or both. We therefore tested the hypothesis that the respiratory efficacy of subglottic jet ventilation via the Mon-Jet catheter can be improved if combined respiratory frequencies are used instead of only a single frequency. The Mon-Jet catheter was originally designed for subglottic monofrequent (i.e., either high- or low-frequency) jet ventilation (6,7). Therefore, we slightly modified the Mon-Jet catheter to enable the application of subglottic combined-frequency jet ventilation and compared this new technique with the standard technique of subglottic low-frequency (15 breaths/min) jet ventilation. To determine the impact of the access route on respiratory efficacy, we further compared subglottic combined-frequency (600 and 15 breaths/min) jet ventilation with supraglottic combined-frequency (600 and 15 breaths/min) jet ventilation.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The jet ventilation laryngoscope serves for the administration of supraglottic jet ventilation, for providing surgical access to laryngeal structures, and for the illumination of the operating field. It is made of steel, and two nozzles for the simultaneous administration of high- and low-frequency jet ventilation are integrated in its wall. A third tube opens close to the tip into the main lumen of the laryngoscope and serves for airway pressure monitoring. A more detailed description of the technique of supraglottic jet ventilation via this specially designed laryngoscope has been published previously (5). The Mon-Jet catheter is made of polytetrafluoroethylene and is composed of two parallel tubes. The central tube is the jet ventilation nozzle. The second lumen serves as a monitoring port. At the tip of the catheter, a basket aligns the catheter with the trachea and prevents direct contact of the jet ventilation nozzle with the tracheal wall. To enable the administration of combined respiratory frequencies, we connected a three-way stopcock to the proximal end of the jet ventilation nozzle of the Mon-Jet catheter. The respirator tubes for high- and low-frequency jet ventilation were then connected to the three-way stopcock with the high-frequency tube at a 180° angle and the low-frequency tube at a 90° angle to the jet nozzle of the Mon-Jet catheter.

Before comparing different jet ventilation techniques in patients, lung simulator tests were performed. Three ventilation techniques were tested: subglottic low-frequency jet ventilation (15 breaths/min), subglottic combined-frequency jet ventilation (15 and 600 breaths/min), and supraglottic combined-frequency jet ventilation (15 and 600 breaths/min). The tests were performed at two different lung simulators’ (LS 800; Dräger, Lübeck, Germany) settings: a) compliance of 133 mL/mm Hg, resistance of 1.5 mm Hg · L-1 · s-1, and b) compliance of 66.5 mL/mm Hg, resistance of 6 mm Hg · L-1 · s-1. The diameter of the trachea on the lung simulator was 11 mm. A jet ventilation respirator for the combined or single administration of high and low respiratory frequencies was used (LJ 4000 Jet Ventilator; Acutronic, Jona-Rappersweil, Switzerland). The inspiration/expiration time ratio was set at 1, and the FIO2 was set at 0.5. The driving pressure was set at 1500 mm Hg. Tracheal FIO2 was monitored with a ventilation gas analyzer (Datex, Helsinki, Finland) that was connected to the monitoring port of the Mon-Jet catheter. The amount of room air entrainment can be very precisely estimated by measuring the difference between the FIO2 of the gas that is delivered by the respirator and the FIO2 that is finally present in the rachea (8). The percentage of the amount of room air entrainment ({image}E) to measured total tidal volume (VT) was calculated as follows: {image}E/VT (%) = ([respirator FIO2 - tracheal FIO2] x 100/tracheal FIO2 - 0.21)/(100 + [respirator FIO2 - tracheal FIO2] x 100/tracheal FIO2 - 0.21).

After approval by our ethics committee and informed consent, 37 adult patients (ASA I–III) scheduled for elective microlaryngeal surgery were prospectively studied. Oral midazolam (7.5 mg) was administered to all patients approximately 60 min before the start of anesthesia. The usual monitoring was used. The anesthetic induction was performed with a continuous infusion of propofol 10 mg · kg–1 · h–1 IV and remifentanil 0.8–1 µg · kg–1 · min–1 IV. After patients’ loss of consciousness, vecuronium 0.1 mg/kg IV was administered, and the Mon-Jet catheter was endotracheally placed. Thereafter, a radial artery cannula was inserted and invasive arterial blood pressure was recorded. For maintenance of anesthesia, the rates of the propofol and remifentanil infusions were reduced to 3–5 mg · kg–1 · h–1 and 0.2–0.4 µg ·kg–1 · min–1, respectively. Then the otolaryngologist inserted the jet ventilation laryngoscope. The same respirator as for the lung simulator tests was used (LJ 4000 Jet Ventilator). The inspiration/expiration time ratio was set at 1 and the FIO2 was set at 0.5. In every patient, the driving pressure was initially adjusted to achieve normocarbia but was not changed throughout the entire study period. The FIO2 was increased by 0.2 if peripheral oxygen saturation decreased to <92%.

The patients were randomly assigned to one of two groups. In Group 1 (n = 18; 10 women, 8 men), subglottic low-frequency (15 breaths/min), subglottic combined-frequency (600 and 15 breaths/min), and again subglottic low-frequency jet ventilation (15 breaths/min) were sequentially performed via the Mon-Jet catheter. In Group 2 (n = 19; 8 women, 11 men), the sequence of ventilation techniques was supraglottic combined-frequency jet ventilation (600 and 15 breaths/min) via the laryngoscope, subglottic combined-frequency jet ventilation (600 and 15 breaths/min) via the Mon-Jet catheter, and again supraglottic combined-frequency jet ventilation (600 and 15 breaths/min) via the laryngoscope. Each of the ventilatory modes was maintained for 15 min in both groups. Arterial blood samples were drawn after 15 min of every ventilatory mode to determine PaO2, PaCO2, and arterial pH (pHa). To assess the CO2-elimination capacity of each ventilation technique, the CO2 elimination coefficient (ECCO2) was calculated (ECCO2 = 56.25 · 103 · driving pressure–1 · PaCO2–1; pressures in mm Hg) (9). If we assume that a normal PaCO2 of 37.5 mm Hg can be achieved with a driving pressure of 1500 mm Hg, ECCO2 equals 1, and it becomes larger or smaller than 1 if CO2 elimination is better or worse than the above described standard constellation (9). Room air entrainment was determined in the same way as during the lung simulator tests.

All statistical analyses were performed with a commercially available computer program (StatView; SAS Institute, Cary, NC). The patients’ age, weight, and height were compared with a Mann-Whitney U-test. Mean arterial pressure and heart rate were recorded in 5-min intervals. Changes in these variables were examined for statistical significance with analysis of variances for repeated measurements. The values of pHa, PaCO2, PaO2/measured FIO2, ECCO2, and room air entrainment after 15 min of each ventilation technique were compared with Wilcoxon’s signed rank test. P < 0.05 was considered statistically significant. Data were presented as mean ± SD if not otherwise specified.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Data obtained from the lung simulator tests are reported in Table 1. In both settings of compliance and resistance, VT during subglottic jet ventilation increased approximately 10-fold by using combined respiratory frequencies instead of only a low frequency. The volume delivered by the respirator (VR) and {image}E increased approximately 10-fold, whereas the ratio of {image}E/VT remained constant. In both lung simulator settings, the largest VT was obtained during supraglottic combined-frequency jet ventilation, which was mainly caused by an increased ratio of {image}E/VT. The VRs were similar between subglottic and supraglottic combined-frequency jet ventilation.


View this table:
[in this window]
[in a new window]
 
Table 1. Data Obtained from Testing the Three Jet Ventilation Techniques on the Lung Simulator with Two Different Settings of Compliance and Resistance
 
Demographic data of the patients of the two study groups were comparable and did not differ significantly: age: 50 ± 13 yr Group 1 vs 45 ± 17 yr Group 2; height: 168 ± 9 cm Group 1 vs 170 ± 10 cm Group 2; weight: 73 ± 14 kg Group 1 vs 72 ± 11 kg Group 2; body surface area: 1.84 ± 0.20 m2 Group 1 vs 1.83 ± 0.16 m2 Group 2. Mean arterial pressure and heart rate did not change significantly during the study period in either of the two groups.

In Group 1, the driving pressure was set at 1305 ± 278 mm Hg (range, 825-1800 mm Hg). The respirator FIO2 was set at 0.55 ± 0.11 (range, 0.50–0.90), 0.55 ± 0.11 (range, 0.50–0.90), and 0.55 ± 0.11 (range, 0.50–0.90) during subglottic low-frequency jet ventilation, subglottic combined-frequency jet ventilation, and the second episode of subglottic low-frequency jet ventilation, respectively. Fifteen minutes after switching from subglottic low-frequency to subglottic combined-frequency jet ventilation, pHa increased (from 7.34 ± 0.06 to 7.38 ± 0.07, P < 0.05), PaCO2 decreased (from 46.6 ± 8.3 to 42.1 ± 8.1 mm Hg, P < 0.05), and PaO2/FIO2 increased (from 311 ± 144 to 361 ± 141 mm Hg, P < 0.05). Fifteen min after switching back to subglottic low-frequency jet ventilation, pHa decreased (to 7.35 ± 0.09, P < 0.05), PaCO2 increased (to 46.2 ± 11.9 mm Hg, P < 0.05), and PaO2/FIO2 decreased (to 315 ± 153 mm Hg, P < 0.05). The changes in pHa, PaCO2, and PaO2/FIO2 during the sequence of ventilation techniques in Group 1 are shown in Figure 1. The ECCO2 was significantly increased during subglottic combined-frequency jet ventilation (1.12 ± 0.36) as compared to the first (1.02 ± 0.37), but not to the second (1.05 ± 0.39, P = 0.08) episode of subglottic low-frequency jet ventilation. The calculated percentage of {image}E/VT was 10.5% ± 10.0% during subglottic low-frequency jet ventilation, 8.2% ± 10.0% during subglottic combined-frequency jet ventilation, and 10.0% ± 10.8% during the second episode of subglottic low-frequency jet ventilation (not significant).



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. Mean ± SD of the individual changes in arterial pH (pHa) (upper panel), PaCO2 (middle panel), and the ratio of PaO2 over inspiratory oxygen fraction (PaO2/FIO2, lower panel). SBGLF->SBGCF: Changes observed after switching from subglottic low-frequency (15 breaths/min) jet ventilation to subglottic combined-frequency (600 and 15 breaths/min) jet ventilation. SBGCF->SBGLF: Changes observed after switching from subglottic combined-frequency jet ventilation back to subglottic low-frequency jet ventilation. Each ventilation technique was maintained for 15 min. Both types of subglottic jet ventilation were performed with the Mon-Jet catheter (Xomed, Jacksonville, FL).

 
In Group 2, the driving pressure was set at 1200 ± 180 mm Hg (range, 900-1500 mm Hg). The respirator FIO2 was set at 0.51 ± 0.02 (range, 0.50–0.60), 0.51 ± 0.05 (range, 0.40–0.70), and 0.50–0.02 (range, 0.40–0.50) during supraglottic combined-frequency jet ventilation, subglottic combined-frequency jet ventilation, and the second episode of supraglottic combined-frequency ventilation, respectively. After switching from supraglottic to subglottic combined-frequency jet ventilation, pHa decreased (from 7.42 ± 0.06 to 7.36 ± 0.07, P < 0.05), PaCO2 increased (from 39.4 ± 7.1 to 45.9 ± 7.5 mm Hg, P < 0.05), and PaO2/FIO2 decreased (from 415 ± 114 to 351 ± 129 mm Hg, P < 0.05). During the second episode of supraglottic combined-frequency jet ventilation, pHa increased again (to 7.41 ± 0.06; P < 0.05), PaCO2 decreased (to 39.9 ± 6.3 mm Hg; P < 0.05), and PaO2/FIO2 increased (to 390 ± 101 mm Hg; P = 0.07). The changes in pHa, PaCO2, and PaO2/FIO2 during the sequence of ventilation techniques in Group 2 are shown in Figure 2. After switching to subglottic combined-frequency jet ventilation, ECCO2 decreased significantly (from 1.25 ± 0.28 to 1.07 ± 0.23), and ECCO2 increased significantly during the second episode of supraglottic combined-frequency jet ventilation (to 1.23 ± 0.27). The calculated percentage of {image}E/VT was significantly greater during the first (57.4% ± 24.2%) and the second (52.2% ± 27.3%) episodes of supraglottic combined-frequency jet ventilation than during subglottic combined-frequency jet ventilation (8.5% ± 17.3%).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Mean ± SD of the changes in arterial pH (pHa) (upper panel), PaCO2 (middle panel), and the ratio of PaO2 over inspiratory oxygen fraction (PaO2/FIO2, lower panel). SPGCF->SBGCF: Changes observed after switching from supraglottic combined-frequency (600 and 15 breaths/min) jet ventilation to subglottic combined-frequency jet ventilation. SBGCF->SPGCF: Changes observed after switching from subglottic combined-frequency jet ventilation back to supraglottic combined-frequency jet ventilation. Each ventilation technique was maintained for 15 min. Supraglottic jet ventilation was performed with a specially designed jet ventilation laryngoscope (Carl Reiner G.m.b.H., Vienna, Austria), and subglottic jet ventilation was performed with the Mon-Jet catheter (Xomed, Jacksonville, FL).

 
Severe hypercapnia (PaCO2 >55 mm Hg) was observed in 38.8% of all measurements during subglottic low-frequency jet ventilation, in 16.2% during subglottic combined-frequency jet ventilation, and in 5.3% during supraglottic combined-frequency jet ventilation. The percentage of patients in whom ECCO2 was <1.0 and <0.6 is reported in Table 2.


View this table:
[in this window]
[in a new window]
 
Table 2. Percentage of Patients in Whom the Carbon Dioxide Elimination Coefficient (ECCO2) was <1.0 and <0.6, Respectively
 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The Mon-Jet catheter was originally designed for monofrequent jet ventilation (6). The jet ventilation nozzle is equipped with a single port for attaching a high-pressure tube of a jet ventilator to it. The Mon-Jet catheter has mostly been used for low-frequency jet ventilation with respiratory frequencies of 10 to 20 breaths/min (6,7). In our previous study, we found that the respiratory efficacy of supraglottic combined-frequency jet ventilation via a specially designed jet ventilation laryngoscope was superior to low-frequency jet ventilation via the Mon-Jet catheter (5). The hypothesis of the present study—that the respiratory efficacy of subglottic jet ventilation via the Mon-Jet catheter can be improved by superimposing low and high respiratory frequencies—was partly confirmed. However, the respiratory efficacy of supraglottic combined-frequency jet ventilation could not be reached by this modification of subglottic jet ventilation via the Mon-Jet catheter. Therefore, supraglottic combined-frequency jet ventilation appears to be one further step toward the optimal combination of ventilatory mode and access route. The additional information obtained from the present study, compared with our previous work, is that both the ventilatory mode and the access route significantly contribute to the performance of jet ventilation techniques—a fact that complicates attempts to compare data from different studies about different jet ventilation techniques. The determination of the PaCO2, which is achieved with a certain driving pressure, and the PaO2, which is achieved at a certain FIO2, is probably the best way to objectively assess the performance of jet ventilation techniques. The inspiration/expiration time ratio and the respiratory frequency may additionally contribute to the respiratory efficacy, and therefore we set these variables equally in all patients with all ventilation techniques studied.

Efforts to increase the respiratory efficacy of jet ventilation techniques are of great clinical importance. Although it is uncomplicated to maintain an adequate pulmonary gas exchange in many patients undergoing microlaryngeal surgery with any ventilation technique, we are increasingly challenged by older patients, or those suffering from severe cardiopulmonary or pulmonary diseases, in whom a normal PaO2 and normocapnia cannot be easily achieved. Frequently, hypoxia and hypercapnia occur during microlaryngeal surgery even though the driving pressure is set at maximum and the FIO2 is 100%. Hunsaker (6) repeatedly observed severe hypercapnia (PaCO2 >55 mm Hg) in 4 of 19 study patients during the evaluation of subglottic low-frequency jet ventilation via the Mon-Jet catheter, particularly if surgery lasted for more than 30 min. In another study about subglottic jet ventilation via the Mon-Jet catheter, severe hypercapnia occurred in 5 of 164 patients despite maximum increases in driving pressure, and surgery could only be completed after switching to conventional mechanical ventilation via an endotracheal tube (9). In the present study, the incidence of severe hypercapnia and an abnormally low ECCO2 was highest during low-frequency jet ventilation; it was lower during subglottic combined-frequency jet ventilation and lowest during supraglottic combined-frequency jet ventilation.

Of prime importance are the physiologic and physical determinants of the respiratory efficacy of a certain jet ventilation technique. Respiratory efficacy is clearly influenced by multiple factors that interact in a system consisting of the lung, the anatomy, and pathologic changes of the laryngeal structures, the ventilatory mode, and the access route by which jet streams are administered. However, we may conclude that the VT is one important determinant of respiratory efficacy. On the lung simulator, VT was markedly larger with ventilation techniques that also showed a better respiratory efficacy in patients. Further, pulmonary gas exchange during jet ventilation was improved with increasing VT, particularly with regard to CO2 removal (5,10). The fact that the VT generated by supraglottic combined-frequency jet ventilation was larger than that generated by subglottic low-frequency and subglottic combined-frequency jet ventilation may, at least in part, be attributable to a larger amount of room air entrainment. The calculated percentages of {image}E/VT with the three jet ventilation techniques studied were similar on the lung simulator and in the patients. The lung simulator tests showed that VR was almost identical between subglottic and supraglottic combined-frequency jet ventilation and that the differences in VT were only caused by an increased {image}E during supraglottic combined-frequency jet ventilation. However, {image}E/VT was similar between subglottic low-frequency and subglottic combined-frequency jet ventilation, although the VT achieved with subglottic combined-frequency jet ventilation was considerably larger than that achieved with subglottic low-frequency jet ventilation. It is therefore impossible that the increase in VT that was generated by combined respiratory frequencies was a result of an increased percentage of {image}E/VT. On the lung simulator, the absolute values of both {image}E and VR differed approximately by a factor of 10 between subglottic low-frequency and subglottic combined-frequency jet ventilation. Because the percentage of {image}E/VT was only around 18% during subglottic jet ventilation via the Mon-Jet catheter, most of the difference in VT between subglottic low-frequency and subglottic combined-frequency jet ventilation resulted from the difference in VR.

In patients, the creation of an (intrinsic) positive end-expiratory pressure, or an increase in gas diffusion to and from the alveolar membranes might additionally have contributed to the better respiratory efficacy of combined-frequency jet ventilation (11,12). The presence of a moderate positive end-expiratory pressure leads to a shift of the lower inflection point on the pressure-volume (compliance) curve to the right, where a large increase in volume results from only small increases in pressure. Thereby, lung areas are recruited that are otherwise collapsed because of a decrease in functional residual capacity during anesthesia (13). This could lead to an increase in PaO2/FIO2, as well as to an improved ECCO2 because of a decrease in mean airway pressure required to administer a given VT. Indeed, residual capacity becomes larger if compliance increases during jet ventilation via the Mon-Jet catheter (9). Perhaps a mechanical lung simulator should not be regarded as an identical model of a lung in a live subject because of major dissimilarities in the complex and inhomogeneous dynamic properties of the human lung and thorax.

Perhaps our study could be biased by changes in oxygen consumption and carbon dioxide production resulting from variations in the metabolic state and depth of anesthesia during the study period. However, the stability of heart rate and arterial blood pressure in these patients suggests that no significant metabolic changes occurred. The anesthesia regimen was standardized and surgical stress was constant because it was primarily caused by suspension laryngoscopy, which was performed during the entire study period in all patients.

We conclude that the respiratory efficacy of subglottic jet ventilation via the Mon-Jet catheter can be improved by superimposing high and low respiratory frequencies. Compared with subglottic low-frequency jet ventilation, an average decrease in PaCO2 by 9.5% and an increase in PaO2/FIO2 by 18% can be expected. However, supraglottic combined-frequency jet ventilation via a jet ventilation laryngoscope is the most efficient of the jet ventilation techniques that we tested. The observed differences in respiratory efficacy may partly be caused by differences in room air entrainment and VT.


    Acknowledgments
 
Supported by the Department of Anesthesiology and General Intensive Care of the University of Vienna.


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Dhara SS, Butler PJ. High frequency jet ventilation for microlaryngeal laser surgery: an improved technique. Anaesthesia 1992; 47: 421–4.[Web of Science][Medline]
  2. Ossoff RH, Duncavage JA. Adult subglottiscope for laser surgery. Ann Otol Rhinol Laryngol 1988; 97: 552–3.[Web of Science][Medline]
  3. Crockett DM, Scamman FL, McCabe BF, et al. Venturi jet ventilation for microlaryngoscopy: technique, complications, pitfalls. Laryngoscope 1987; 97: 1326–30.[Web of Science][Medline]
  4. Koufman JA, Little FB, Weeks DB. Proximal large-bore jet ventilation for laryngeal laser surgery. Arch Otolaryngol Head Neck Surg 1987; 113: 314–20.
  5. Bacher A, Pichler K, Aloy A. Supraglottic combined frequency jet ventilation versus subglottic monofrequent jet ventilation in patients undergoing microlaryngeal surgery. Anesth Analg 2000; 90: 460–5.[Abstract/Free Full Text]
  6. Hunsaker DH. Anesthesia for microlaryngeal surgery: the case for subglottic jet ventilation. Laryngoscope 1994; 104: 1–30.[Web of Science][Medline]
  7. Brooker CR, Hunsaker DH, Zimmermann AA. A new anesthetic system for microlaryngeal surgery. Otolaryngol Head Neck Surg 1998; 118: 55–60.[Web of Science][Medline]
  8. Gaughan SD, Benumof JL, Ozaki GT. Quantification of the jet function of a jet stylet. Anesth Analg 1992; 74: 580–5.[Abstract/Free Full Text]
  9. Biro P, Eyrich G, Rohling RG. The efficiency of CO2 elimination during high-frequency jet ventilation for laryngeal microsurgery. Anesth Analg 1998; 87: 180–4.[Abstract/Free Full Text]
  10. Korvenranta H, Carlo WA, Goldthwait DA Jr, Fanaroff AA. Carbon dioxide elimination during high-frequency jet ventilation. J Pediatr 1987; 111: 107–13.[Web of Science][Medline]
  11. Spackman DR, Kellow N, White SA, et al. High frequency jet ventilation and gas trapping. Br J Anaesth 1999; 83: 708–14.[Abstract/Free Full Text]
  12. Scherer PW, Muller WJ, Raub JB, Haselton FR. Convective mixing mechanisms in high frequency intermittent jet ventilation. Acta Anaesthesiol Scand Suppl 1989; 90: 58–64.[Medline]
  13. Wahba RM. Airway closure and intraoperative hypoxaemia: twenty-five years later. Can J Anaesth 1996; 43: 1144–9.[Web of Science][Medline]
Accepted for publication August 1, 2000.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. Rezaie-Majd, W. Bigenzahn, D.-M. Denk, M. Burian, J. Kornfehl, M. Ch. Grasl, G. Ihra, and A. Aloy
Superimposed high-frequency jet ventilation (SHFJV) for endoscopic laryngotracheal surgery in more than 1500 patients
Br. J. Anaesth., May 1, 2006; 96(5): 650 - 659.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. A. Baer
What to Prefer During Jet Ventilation for Endolaryngeal Procedures, Risk of Barotrauma or of Aspiration of Contaminating Material?
Anesth. Analg., December 1, 2001; 93(6): 1625 - 1625.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bacher, A.
Right arrow Articles by Aloy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bacher, A.
Right arrow Articles by Aloy, A.


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2000 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press